Endomagnetics announced it has reached an agreement with Aurora BioScience as its exclusive distributor for Australia and New Zealand. This appointment significantly extends the availability of its SentiMag and Sienna+ tracer system. Breast cancer patients in the region will now have access to new technology that optimally locates lymph nodes as part of the cancer staging procedure in Sentinel Lymph Node Biopsy (SLNB).